首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1358036

客製化重組蛋白生產服務市場：依表達系統、最終用戶、地區

Custom Recombinant Protein Production Services Market, By Expression System, By End User, By Region

出版日期: 2023年09月14日 | 出版商:

Coherent Market Insights | 英文 207 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球客製化重組蛋白生產服務市場將達到 49 億美元，預計在預測期內（2023-2030 年）年複合成長率為 11.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	49億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	11.50%	2030年市場規模預測	105億美元

客製化重組蛋白生產服務的全球市場佔有率(%)，依表現系統，2023 年

重組蛋白在生物技術、研究和醫學領域有廣泛的用途。客製化重組蛋白生產是生命科學領域使用的有效技術之一，在先進的醫療保健中發揮重要作用。重組蛋白是透過使用特定技術操縱蛋白質而開發的。然後這些基因被用來編碼這些重組蛋白，這些重組蛋白被大量生產並用於製造治療劑和商業產品。政府在生命科學領域的配合措施和資金的增加預計將促進市場成長。

許多重組蛋白需要並提供轉譯後修飾，例如僅在真核生物、酵母、哺乳動物和昆蟲細胞培養系統中可用的糖基化。 HEK293 衍生細胞株用於瞬時蛋白質生產。目前，大多數重組治療性蛋白質是在哺乳動物細胞中產生的，因為它們能夠產生與自然界中發現的類似的高品質蛋白質。此外，許多核准的重組治療性蛋白質都是在大腸桿菌中產生的，因為它們具有良好的遺傳特徵，生長迅速，並且可以高產量生產。

市場動態

預計主要企業擴大採用無機成長策略（例如主要參與者的收購）將推動該部門市場在預測期內的成長。例如，2021年7月，經過高度檢驗的一抗製造商Atlas Antibodies收購了中國倉鼠卵巢（CHO）細胞中瞬時重組抗體表達開發商Evitria。 CHO 細胞是重組治療蛋白 (RTP) 生產的合適表現系統。此次收購將結合兩家公司的抗體解決方案並擴大各自的業務。

本研究的主要特點

本報告詳細分析了全球客製化重組蛋白生產服務市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
它還闡明了各個部門市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務實績和策略等參數，介紹了全球客製化重組蛋白生產服務市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
全球客製化重組蛋白生產服務市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球客製化重組蛋白生產服務市場的各種策略矩陣來促進他們的決策。

公司簡介
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials（abm）Inc.
- Eurofins Pharma Discovery Services
- Abgent（WuXi AppTec Company）
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron

第9章章節

參考
調查方法
關於出版商並聯絡方式我們

簡介目錄

Product Code: CMI2737

The global custom recombinant protein production services market is estimated to be valued at US$ 4.9 billion in 2023 and is expected to exhibit a CAGR of 11.5% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 4.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	11.50%	2030 Value Projection:	US$ 10.5 Bn

Global Custom Recombinant Protein Production Services Market Share (%), By Expression System, 2023

Custom Recombinant Protein Production Services Market - IMG1

Recombinant proteins have a wide range of applications in biotechnology, research, and medicine. Custom recombinant protein production is one of the efficient techniques used in the life sciences sector that plays a major role in advanced healthcare. Recombinant proteins are developed by manipulating proteins using certain techniques. Genes are then used to encode these recombinant proteins, which are then produced in large quantities and used to make therapeutic and commercial products. Increasing government initiatives and funding in the field of life sciences is expected to boost growth of the market.

Many recombinant proteins require and provide post-translational modifications such as glycosylation, which are only available in eukaryotic, yeast, mammalian, and insect cell culture systems. HEK293-derived cell lines are used for transient protein production. Currently, most recombinant therapeutic proteins are produced in mammalian cells due to their ability to produce high-quality proteins similar in nature. In addition, many approved recombinant therapeutic proteins have been produced in E. coli due to well-characterized genetics, rapid growth, and high-yield production.

Market Dynamics

The increasing adoption of inorganic growth strategies such as acquisitions by the key players is expected to drive segment growth over the forecast period. For instance, in July 2021, Atlas Antibodies, a manufacturer of highly validated primary antibodies, acquired Evitria, a developer of transient recombinant antibody expression in Chinese hamster ovary (CHO) cells. CHO cells are the preferred expression system for recombinant therapeutic protein (RTP) production. The acquisition will combine the antibody solutions of both companies and expand their businesses.

Key features of the study:

This report provides an in-depth analysis of the global custom recombinant protein production services market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global custom recombinant protein production services market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include GenScript Biotech Corporation, SignalChem Biotech Inc., Crown Bioscience, Inc., BPS Bioscience Inc., Novoprotein, Applied Biological Materials (abm) Inc., Eurofins Pharma Discovery Services, Abgent (WuXi AppTec Company), OriGene Technologies, Inc., Kempbio, Inc., Trenzyme GmbH, Sino Biological Inc., Aragen Bioscience, a GVKBIO Company, LakePharma, Inc., , Proteos Inc., Icosagen AS, Novus Biological LLC, Proteogenix, Premas Biotech, ATUM, and Aldevron
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global custom recombinant protein production services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global custom recombinant protein production services market.

Custom Recombinant Protein Production Services Market Detailed Segmentation:

By Expression System:
- Mammalian
- Bacteria
- Insect
- Yeast
- Others
By End User :
- Research Institutes
- Biotechnology and Pharmaceutical Companies
- Contract Research Organizations
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GenScript Biotech Corporation
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- OriGene Technologies, Inc.
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.,
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Expression System
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Custom Recombinant Protein Production Services Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Custom Recombinant Protein Production Services Market, By Expression System , 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Mammalian
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Bacteria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Insect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Yeast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

6. Global Custom Recombinant Protein Production Services Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Custom Recombinant Protein Production Services Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Expression System , 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By End User, 2018 -2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- GenScript Biotech Corporation
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- SignalChem Biotech Inc.
- Crown Bioscience, Inc.
- BPS Bioscience Inc.
- Novoprotein
- Applied Biological Materials (abm) Inc.
- Eurofins Pharma Discovery Services
- Abgent (WuXi AppTec Company)
- Kempbio, Inc.
- Trenzyme GmbH
- Sino Biological Inc.
- Aragen Bioscience, a GVKBIO Company
- LakePharma, Inc.
- Proteos Inc.
- Icosagen AS
- Novus Biological LLC
- Proteogenix
- Premas Biotech
- ATUM
- Aldevron